Navigation Links
deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
Date:11/10/2008

g stroke, and physicians can immediately take this new information into the clinic through the use of the same test. This has implications for the prevention of recurrent stroke, because most patients who have suffered a cryptogenic or large vessel event are discharged and put on Plavix or aspirin, which have little impact in preventing AF. Testing all of their stroke and TIA patients with deCODE AF(TM), doctors can identify those who should be monitored for AF. And for those who evidence AF, warfarin may be the best therapy. With our partner Medicomp we are now planning a multicenter study pairing the use of deCODE AF(TM) with ambulatory digital cardiac monitors, in order to demonstrate the impact that improving the detection of AF cna have on the prevention of stroke," said Dr. Kari Stefansson, M.D., Dr. Med., CEO of deCODE, a board-certified neurologist and neuropathologist.

About deCODE AF(TM) and this study

In 2007, deCODE discovered two SNPs on chromosome 4q25 that double the risk of atrial fibrillation, and later that year launched deCODE AF(TM) to enable doctors to detect these SNPs in their patients. In the study discussed above, deCODE conducted a genome-wide association study to identify risk variants for stroke. The deCODE team analyzed more than 300,000 single latter variations (SNPs) across the genomes of more than 35,000 stroke patients and control subjects from several discovery and replication cohorts from the United States and Europe. The 4q25 SNPs in the deCODE AF test - called rs10033464 and rs2200733 - were the only markers found to confer significantly increased risk of ischemic stroke in general and carioembolic stroke in particular. This was not unexpected, because AF is such a major risk for ischemic stroke. However rs2200733 was also strongly associated with increased risk of non-cardiogenic stroke as well.

How to order deCODE AF(TM)

Additional information and physician order forms for deCODE AFr(TM) can be found
'/>"/>

SOURCE deCODE genetics Inc
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. deCODE genetics Announces Third Quarter 2008 Financial Results
2. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
3. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
4. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
5. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
6. Researchers decode viral process that prepares cells for HIV infection
7. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
8. deCODE genetics Announces Second Quarter 2008 Financial Results
9. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
10. deCODE genetics to Webcast Presentations at Annual R&D Event
11. deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 In a ... industry suppliers will present technologies with applications in ... annual SPIE Optics and Photonics symposium ... SPIE, the international society for optics and ... multidisciplinary optical sciences and technology meeting in North ...
(Date:5/24/2013)... Toronto, Canada (PRWEB) May 24, 2013 ... selective barriers, and uptake or efflux transporters at the ... may be related to unbound fractions in the tissue ... understanding of these disposition challenges is required to guide ... and to identify any species-dependent variables that may impact ...
(Date:5/23/2013)... stopped breathing, his collapsed bronchus blocking the crucial flow ... watched helplessly, just praying that somehow the dire predictions ... had a good chance of not leaving the hospital ... Kaiba. "At that point, we were desperate. Anything that ... it." , They found hope at the University of ...
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2
... up to ... $385 million plus royalties -, PALO ALTO, ... announced today that it has entered into an agreement,granting exclusive ... countries to the Menarini Group. Menarini,with its significant pan-European presence, ...
... Management,Slate of InSite Vision, Including the Chairman and ... Sept. 11 PTV Sciences,("PTV"), a healthcare venture ... that RiskMetrics Group -(Formerly known as ISS), the ... that the,stockholders of InSite Vision Incorporated (Amex: ...
... 11 A project to advance,research and improve ... by a,new $1.6 million, three-year cooperative agreement with ... The agreement, intended to bring better care to ... National Fragile X Foundation (NFXF),the CDC,s National Center ...
Cached Biology Technology:CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 2CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 3CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 4CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group 5RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 2RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 3RiskMetrics (ISS), An Independent Proxy Advisory Firm, Recommends Voting the GOLD Card for Four of PTV's Nominees: Anderson, McInerney, Melrose, and O'Holla 4$1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope 2
(Date:5/24/2013)... combat metastatic cancer , Cancer cells spread and ... system. Stimulation of the immune system can help to ... cause the immune system to ignore cancer cells. Regulatory ... the immune system response. In this issue of the ... Ronald Levy at Stanford University found that regulatory T ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
(Date:5/23/2013)... National Laboratory honored more than 165 staff for ... at PNNL,s annual Intellectual Property Commercialization Recognition & ... Energy national laboratory named materials scientist Jun Liu ... battery materials that can store large amounts of ... reduce the time it takes to charge cell ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... , DNA-Prokids ( http://www.dna-prokids.org ), an international project ... victims and their relatives, was officially presented today, at the ... Traffic in human beings is one of the most ... century. According to data from the United Nations Office on ...
... rapid growth of institutional Memberships for open access ... of the "Online Reporting System" for its open ... BioMed Central,s cutting edge publishing platform, the new ... and help reduce the administrative costs associated with ...
... Stedim Biotech (SSB) and Adolf Kühner AG ,- Prototype ... ,Monthey, 19. Mai 2009 / b3c newswire ... to the biopharmaceutical industry, expands its product offering with ... OrbShake bioreactors rely on orbital shaking principles for ...
Cached Biology News:DNA-Prokids: Genetic identification against traffic in human beings 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 2ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor 3
... and M.W. Turner (1997). ... step-by-step methods for the ... molecules, the use of ... analytical probes and as ...
Request Info...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
... Maker, 1. Modular system for large ... up to six lab-cast or precast ... with 18- or 24-cm Immobiline DryStrip ... gel cassettes.Innovative design simplifies loading and ...
Biology Products: